Functional insulin receptors are overexpressed in thyroid tumors: Is this an early event in thyroid tumorigenesis?

Cancer

Volumn 85, Issue 2, 1999, Pages 492-498

  Frittitta, Lucia ^a   Sciacca, Laura ^a   Catalfamo, Rosaria ^a   Ippolito, Antonio ^a   Gangemi, Pietro ^b   Pezzino, Vincenzo ^a   Filetti, Sebastiano ^c   Vigneri, Riccardo ^a  

^a GARIBALDI HOSPITAL   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Policlinico Mater Domini   (Italy)

Author keywords

Insulin; Insulin receptor; Thyroid adenoma; Thyroid carcinoma

Indexed keywords

INSULIN; INSULIN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; DISEASE CLASSIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; THYROID ADENOMA; THYROID TUMOR;

CELLS, CULTURED; HUMANS; PROGNOSIS; RADIOIMMUNOASSAY; RECEPTOR, INSULIN; THYROID GLAND; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032916513     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990115)85:2<492::AID-CNCR30>3.0.CO;2-I     Document Type: Article

References (32)

1. Dumont JE, Lamy F, Roger P, Maenhaut C. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 1992;72:667-97.
2. Nagayama Y, Rapoport B. The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. Mol Endocrinol 1992;6:145-56.
3. Condorelli G, Formisano P, Miele C, Beguinot F. Thyrotropin regulates autophosphorylation and kinase activity in both the insulin and the insulin-like growth factor-I receptors in FRTL-5 cells. Endocrinology 1992;130:1615-25.
4. Ullrich A, Bell JR, Chen EY, Herrera A, Petruzzelli LM, Dull TJ, et al. Human insulin receptor and its relationship to the tyrosine-kinase family of oncogenes. Nature 1985:313:756-61.
5. Trischitta V, Damante G, Foti D, Filetti S. Insulin binding and biological activity in the FRTL-5 rat thyroid cell line. Metabolism 1987;36:379-83.
6. Santisteban P, Acebron A, Polycarpou-Schwarz M, Di Lauro R. Insulin and Insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter. Mol Endocrinol 1992;6:1310-7.
7. Shimura Y, Shimura H, Ohmori M, Ikuyama S, Konh LD. Identification of a novel insulin-responsive element in the rat thyrotropin receptor promoter. J Biol Chem 1994;269: 31908-14.
8. Cezard JP, Forgue-Lafitte ME, Chamblier MC, Rosselin GE. Growth-promoting effect, biological activity, and binding of insulin in human intestinal cancer cells in culture. Cancer Res 1981;41:1148-53.
9. Mountjoy KG, Holdway IM, Finlay GJ. Insulin receptor regulation in cultured human tumor cells. Cancer Res 1983;43: 4537-42.
10. Yamanouchi T, Tsushina T, Akanuma Y, Kasuga M, Mizoguchi H, Takaku F. Characteristics of IRs and insulin action in human myelogenous leukemia cell line K-562. Diabetes 1985;34:347-52.
11. Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R, et al. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 1992:52: 3924-30.
12. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, et al. Elevated insulin receptor content in human breast cancer. J Clin Invest 1990;85:1503-10.
13. Hedinger C, Williams ED, Sabin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989;63:908-11.
14. Pezzino V, Papa V, Trischitta V, Brunetti A, Goodman PA, Treutelaar MK, et al. Human insulin receptor radioimmunoassay: applicability to insulin-resistant states. Am J Physiol 1989;257:E451-7.
15. La Barca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980;102:344-52.
16. Forsayeth IR, Montemurro A, Maddux BA, De Pirro R, Goldfine ID. Effect of a monoclonal antibodies of human insulin receptor autophosphorylation, negative cooperativity, and down regulation. J Biol Chem 1987;262:4134-40.
17. Fabien N, Fusco A, Santoro M, Barbier Y, Dubois PM, Paulin C. Description of human papillary thyroid carcinoma cell line. Cancer 1994;73:2206-12.
18. Filetti S, Damante G, Foti D. Thyrotropin stimulates glucose transport in cultured rat thyroid cells. Endocrinology 1987; 120:2576-81.
19. Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, du Villard JA, et al. Genetic alterations in thyroid hyper-functioning adenomas. J Clin Endocrinol Metab 1995;80: 1347-51.
20. Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res 1996; 56:2781-8.
21. Namba H, Rubin SA, Fagin JA. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol Endocrinol 1990;4:1474-9.
22. Manenti G, Pilotti S, Re FC, Della Porta G, Pierotti MA. Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas. Ew J Cancer 1994;30A:987-93.
23. Suarez HG, du Villard JA, Severino M, Caillou B, Schlumberger M, Tubiana M, et al. Presence of mutiations in all three ras genes in human thyroid tumors. Oncogene 1990;5: 565-70.
24. Wynford-Thomas D. Molecular genetics of thyroid cancer. Curr Opin Endocr Diab 1995;2:429-36.
25. van der Laan BF, Freeman JL, Asa SL. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues. Thyroid 1995;5:67-73.
26. Vannelli GB, Barni T, Modigliani U, Paulin I, Serio M, Maggi M, et al. Insulin-like growth factor-I receptors in nonfunctioning thyroid nodules. J Clin Endocrinol Metab 1990;71: 1175-82.
27. Brabant G, Maenhaut C, Kohrle J, Scheumann G, Dralle H, Hoang-Vu C, et al. Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol 1991;82:R7-12.
28. Clark OH, Gerend PL. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms. Surgery 1985; 106:967-74.
29. Mazzaferri EL, Young RL, Oertel JE, Kemmerer WT, Page CP. Papillary thyroid carcinoma: the impact of therapy in 576 patients. Medicine 1977;56:171-96.
30. Filetti S, Belfiore A, Amir SM, Daniels GH, Ippolito O, Vigneri R, et al. The role of thyroid stimulating antibodies of Graves' disease in differentiated thyroid cancer. N Engl J Med 1988; 318:753-9.
31. Burmeister LA, Goumaz MO, Mariash CN, Oppenheimer JH. Levothyroxine dose requirements for thyrotropin suppressionin the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 1992;75:344-50.
32. Nicoloff JT, Spencer CA. Editorial: Non- thyrotropin-dependent thyroid secretion. J Clin Endocrinol Metab 1992; 75:343.